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Human telomeres are protected by shelterin, a
complex that includes the POT1 single-stranded
DNAbinding protein.We found thatmouse telo-
meres contain two POT1 paralogs, POT1a and
POT1b, and we used conditional deletion to de-
termine their function. Double-knockout cells
showed that POT1a/b are required to prevent
a DNA damage signal at chromosome ends, en-
doreduplication, and senescence. In contrast,
POT1a/bwere largely dispensable for repression
of telomere fusions. Single knockouts and com-
plementation experiments revealed that POT1a
and POT1b have distinct functions. POT1a, but
not POT1b, was required to repress a DNA dam-
age signal at telomeres. Conversely, POT1b,
but not POT1a, had the ability to regulate the
amount of single-stranded DNA at the telomere
terminus. We conclude that mouse telomeres
require two distinct POT1 proteins whereas
human telomeres have one. Such divergence
is unprecedented in mammalian chromosome
biology and has implications for modeling hu-
man telomere biology in mice.
INTRODUCTION
Genome integrity in mammals requires shelterin, a protein
complex that associates with the telomeric TTAGGG re-
peat array, regulates telomere length, and protects chro-
mosome ends (reviewed in (de Lange, 2005)). Shelterin
contains two DNA binding factors, TRF1 and TRF2, which
anchor the complex along the double-stranded telomeric
repeat array and recruit the shelterin components TIN2,
TPP1 and Rap1. The sixth partner in shelterin is the
single-stranded TTAGGG repeat binding protein, POT1,
which associates with telomeres through its interaction
with TPP1. Shelterin is ubiquitous and abundant at telo-
meres throughout the cell cycle. TRF1, TRF2, TIN2, and
Rap1 are essential in the mouse ((Celli and de Lange,2005; Chiang et al., 2004; Karlseder et al., 2003); T.d.L.
and M. van Overbeek, unpublished data). Here, we de-
scribe the phenotype of POT1-deficient mouse cells.
The protective function of shelterin and the fate of dys-
functional telomeres has been deduced from the pheno-
types associated with deletion of mouse TRF2 and inhibi-
tion of human TRF2 with a dominant-negative allele (Celli
and de Lange, 2005; van Steensel et al., 1998). When
TRF2 is compromised, telomeres are recognized as sites
of DNA damage and processed as if they represent dou-
ble-strand breaks. DNA damage response factors accu-
mulate at chromosome ends, and the ATM kinase signal-
ing pathway is activated, leading to cell cycle arrest and
apoptosis or senescence (Celli and de Lange, 2005;
d’Adda di Fagagna et al., 2003; Karlseder et al., 1999;
Takai et al., 2003). The dysfunctional telomeres become
a substrate for the nonhomologous end-joining (NHEJ)
pathway by which DNA ligase IV joins most of the chromo-
some ends, creating long trains of fused chromosomes
(Celli and de Lange, 2005; Smogorzewska et al., 2002;
van Steensel et al., 1998). The single-stranded telomeric
overhang is attacked by an NHEJ-dependent processing
step, whereas the rest of the telomeric DNA appears to
remain intact, leading to the presence of TTAGGG repeats
at the sites of chromosome-end fusion (Celli and de
Lange, 2005; Zhu et al., 2003).
A model has been proposed for the repression of NHEJ
at mammalian telomeres (Griffith et al., 1999; de Lange,
2005). This model is based on the observation that mam-
malian telomeres can occur in an altered configuration,
the t-loop, in which the 30 telomeric overhang is strand-
invaded into the duplex part of the telomeres (de Lange,
2005; Griffith et al., 1999). Since the NHEJ pathway relies
on the loading of the Ku70/80 heterodimer on free DNA
ends, t-loops could block NHEJ from accessing the chro-
mosome end. The speculation is that loss of TRF2 results
in opening of the t-loop, thus exposing the chromosome
ends to Ku70/80 and enabling NHEJ. TRF2 has been im-
plicated in the formation of t-loops based on its ability to
generate similar structures in model substrates in vitro
(Stansel et al., 2001). However, the role of TRF2 in t-loop
formation in vivo has not been tested. It is also not known
whether the t-loop configuration occurs at all telomeres
and persists throughout the cell cycle.Cell 126, 63–77, July 14, 2006 ª2006 Elsevier Inc. 63
POT1 was discovered based on its sequence similarity
to proteins from hypotrichous ciliates that bind to the short
single-stranded protrusion of the abundant chromosome
ends in their macronuclei (Baumann and Cech, 2001).
These ciliate telomere terminus factors recognize the se-
quence of the telomeric overhang in the context of a 30
end. Structural analysis of the Oxytricha telomeric protein
(TEBPa/b) showed that the complex hides the 30 terminus
in a deep hydrophobic protein pocket, a configuration that
is thought to protect telomeres from inappropriate attack
by nucleases (Horvath et al., 1998). In agreement with
this proposal, the fission yeast ortholog of TEBPa, POT1,
is required for the protection of telomeres from rapid deg-
radation (Baumann and Cech, 2001). The structure of its
DNA binding domain showed that human POT1 might
position the 30 terminus of its 50-TTAGGGTTAG-30 binding
site in a protein pocket, leading to the proposal that the
protection of mammalian telomeres largely depends on
POT1 (Lei et al., 2004). According to this model, the telo-
mere deprotection phenotype of TRF2/ cells could be
due to loss of POT1, since POT1 loading is in part depen-
dent on TRF2 (Loayza and de Lange, 2003). The prediction
of this model is that POT1 deficiency will generate a telo-
mere deprotection phenotype similar to the phenotype of
TRF2 loss.
In order to address the phenotype of POT1 deficiency,
we and others have used RNAi and overexpression of hu-
man POT1 mutant alleles that do not bind single-stranded
DNA (Hockemeyer et al., 2005; Liu et al., 2004; Loayza
and de Lange, 2003; Veldman et al., 2004; Yang et al.,
2005; Ye et al., 2004). In both settings, telomere length
became deregulated, leading to excessive addition of
telomeric repeats by telomerase (Liu et al., 2004; Loayza
and de Lange, 2003; Ye et al., 2004). POT1 depletion
also changed the structure of the telomere terminus
(Hockemeyer et al., 2005). The amount of single-stranded
telomeric DNA was diminished and the 50 telomere end
was altered from its precise [CCCAAT]nC-50 sequence
to a random position. Knockdown of POT1 also resulted
in a DNA damage response but the response was tran-
sient, unlike the phenotype of TRF2 loss, and did not
cause cell cycle arrest in immortalized cells (Hockemeyer
et al., 2005). Furthermore, POT1 knockdown failed to elicit
the severe telomere fusion phenotype observed upon inhi-
bition of TRF2. However, as these experiments involve
a partial (<10-fold) reduction of POT1, the exact role of
POT1 in telomere protection remained to be determined.
Here, we use gene targeting in the mouse to address the
function of mammalian POT1.
RESULTS
Two Distinct POT1 Proteins at Mouse Telomeres
The human genome contains only one gene with signifi-
cant homology to the ciliate telomere terminus proteins
(Baumann and Cech, 2001), and a single POT1 gene is
present in the primate, dog, and cow genomes (Figures
1A, 1B, and Figure S1A in the Supplemental Data available64 Cell 126, 63–77, July 14, 2006 ª2006 Elsevier Inc.with this article online). In contrast, we identified two POT1
orthologs (POT1a and POT1b) in the mouse and rat ge-
nomes (Figures 1A and 1B). Mouse POT1a and POT1b
show 71%–75% amino acid identity to human POT1 and
to each other (Figures S1B and S1C). The mouse POT1a
locus on chromosome 6 is syntenic with the human
POT1 locus on chromosome 7; POT1b is located on
mouse chromosome 17. The most likely origin of the two
rodent POT1 genes is a recent gene duplication (Fig-
ure 1B). Both POT1 mRNAs are represented in the EST
databases (POT1a: AK036052; POT1b: XM_355022) and
appeared ubiquitously expressed based on RT-PCR (Fig-
ure 1C). The embryonic expression pattern of POT1a was
examined using mice derived from a gene-trap ES cell line
containing a b-galactosidase-neo (GEO) fusion gene in-
serted after the 8th coding exon in the POT1a locus
(POT1a8GEO; Figure S1D and see below). Heterozygous
POT1a8GEO/+ E13.5 embryos had b-galactosidase activity
in the developing tissues (Figure 1D), indicating (near)
ubiquitous expression during embryonic development.
Both POT1 proteins were detectable in immunoblots of
extracts from mouse embryo fibroblasts (MEFs), ES cells,
and NIH3T3 cells (Figure 1E). Two anti-sera raised against
POT1a peptides detected a protein of 70 kDa apparent
MW whose abundance was significantly reduced by
shRNAs specific to POT1a. Similarly, two anti-sera raised
to POT1b peptides reacted with a protein of 75 kDa
apparent MW, that was identified as POT1b based on
shRNA knockdown. Immunoblots and immunoprecipita-
tion experiments indicated that the POT1a and POT1b
antibodies were specific to the respective POT1 proteins
(Figure 1E and data not shown). Semiquantitative immu-
noblotting experiments using recombinant proteins as a
standard suggested that POT1a and POT1b are ex-
pressed at similar levels (Figure S1E).
Indirect immunofluorescence (IF) for POT1a and POT1b
revealed the punctuate nuclear pattern typical of telo-
meres and many of the POT1 sites coincided with TRF1
signals (Figure 1F). Telomeric localization was also ob-
served for myc-tagged POT1a and POT1b (see below,
Figure S3B). Furthermore, chromatin immunoprecipitation
(ChIP) with POT1a and POT1b antibodies recovered ap-
proximately the same amount of telomeric DNA but no
chromosome-internal sequences, confirming that both
proteins are specifically associated with telomeres (Fig-
ures 1G and S1F, and data not shown). RNAi-mediated
partial (70%) depletion of POT1a or POT1b demon-
strated the specificity of the antibodies used in these
experiments (Figures 1G and S1F).
Lack of POT1a Results in Embryonic Lethality,
whereas POT1bSTOP/STOP Mice Are Viable and Fertile
Whereas ES cells and mice heterozygous for the gene-
trap allele POT1a8GEO had no apparent phenotype, inter-
crosses of POT1a8GEO/+ mice failed to yield homozygous
offspring (Figure 2). POT1a8GEO/8GEO blastocysts failed
to yield ES cells and cultured E1.5–E3.5 embryos did not
form an inner cell mass and died around E6.5 (data not
Figure 1. Two POT1 Proteins in the Mouse
(A) Schematic of the human and mouse POT1 proteins. Dark fill, OB folds; light fill, TPP1 interacting domain.
(B) Phylogenetic tree of vertebrate POT1 proteins based on the sequences given in Figure S1A using the Multalin website and default settings (http://
prodes.toulouse.inra.fr/multalin/).
(C) Expression of POT1a and POT1b mRNAs in the indicated tissues and embryonic stages determined by RT-PCR.
(D) b-galactosidase staining of E13.5 embryos.
(E) Immunoblots for POT1a and POT1b on extracts from NIH3T3 cells with shRNAs to POT1a (a1 or a3) or POT1b (b1–b3). vec, vector control; a*,
ineffective POT1a shRNA.
(F) IF for POT1a and POT1b in NIH 3T3 cells. IF with mouse anti-POT1a and POT1b sera (green) and rabbit anti-TRF1 (644) (red).
(G) Telomeric DNAChIP for POT1a and POT1b. ChIPs with the indicated antibodies on NIH3T3 cells infected with shRNAs described in panel (E). Left:
TTAGGG signal. Right: Bulk DNA detected with the BamHI repeat. For quantification, see Figure S1F.shown). According to these data, POT1a is essential in
early embryonic development and ES cells, even though
POT1b is expressed (Figures 1C and 2E), suggesting
that POT1a and POT1b are not redundant. We therefore
generated mice carrying targeted alleles allowing con-
ditional deletion of the third coding exon of POT1a,
POT1b, or both. Analogous strategies were used for the
POT1a and POT1b loci (Figures 2A and S2A); a detailed
rationale for the targeting strategy is given in the Supple-
mental Data. The targeting construct introduced an FRT-
flanked STOP cassette (Jackson et al., 2001) after the sec-
ond coding exon, interrupting the first OB-fold of the DNA
binding domain (Figure S1B). Cells heterozygous for the
STOP allele showed50% less POT1a (or POT1b) protein
(Figures 2E and 2G), consistent with previous data on the
STOP cassette (Jackson et al., 2001). Intercrosses ofPOT1aSTOP/+ mice confirmed that POT1a deficiency is in-
compatible with mouse development (Figure 2C). How-
ever, POT1bSTOP/STOP mice appeared healthy and fertile
(Figures 2C and 2D). MEFs isolated from POT1bSTOP/STOP
embryos lacked POT1b (Figure 2E), and ChIP confirmed
that POT1b was not present at telomeres whereas
POT1a, TRF1, and TRF2 remained bound (Figure 2F).
The targeting strategy was such that floxed alleles of
POT1a and POT1b could be generated allowing the isola-
tion of MEFs from which the third protein coding exon (re-
ferred to as exon 3) of either gene could be deleted with
Cre recombinase. Multiple independent POT1aSTOP/FLOX
and POT1bSTOP/FLOX MEFs were isolated and immortal-
ized with SV40 large T antigen (SV40-LT). Cre recombi-
nase efficiently excised exon 3 as shown by PCR and
RT-PCR and resulted in the expected loss of POT1a andCell 126, 63–77, July 14, 2006 ª2006 Elsevier Inc. 65
Figure 2. Conditional Deletion of POT1a and POT1b
(A) Targeting strategy for POT1a. Coding exons 1–5 of the POT1a genomic locus (chromosome 6), the targeting construct, and the POT1a alleles
generated are shown. Yellow, probes used for genotyping (see Figure S2B); green boxes, FRT sites; blue, LoxP sites; SA, splice acceptor.66 Cell 126, 63–77, July 14, 2006 ª2006 Elsevier Inc.
POT1b protein (Figures 2E, 2G, S2C, and S2D). Upon Cre-
mediated deletion of either POT1gene, the other POT1pa-
ralog, TRF1, TRF2, and Rap1 remained associated with
telomeres (see Figures 3 and 5 below anddata not shown).
Redundant Roles for POT1a and POT1b
in Cell Proliferation
Cre-mediated deletion of either POT1a or POT1b from
SV40-LT immortalized MEFs did not lead to a growth
arrest (Figure 2H and data not shown). Both cell types
continued to proliferate with unaltered cellular morphol-
ogy although POT1a-deficient cells grew slightly slower
than the controls. Similarly, deletion of POT1a from pri-
mary MEFs did not result in a growth arrest (data not
shown); POT1b deficiency is tolerated in the context of
the whole animal, indicating that POT1b is also not re-
quired for proliferation of nontransformed cells. In con-
trast, simultaneous Cre-mediated deletion of POT1a and
POT1b from POT1aSTOP/FLOXPOT1bSTOP/FLOX MEFs re-
sulted in a rapid proliferative arrest (Figure 2H). These
double-knockout (DKO) cells appeared to undergo senes-
cence, as deduced from their enlarged and flattened mor-
phology and their expression of SA-b-galactosidase (Fig-
ure 2I). The cultures were eventually overtaken by the
small fraction of cells in which the Cre-mediated deletion
of POT1a and/or POT1b was incomplete (Figure 2H and
data not shown), hampering long-term analysis of DKO
cells. POT1aSTOP/FLOXPOT1bSTOP/FLOX MEFs, which con-
tain half the normal level of POT1a and POT1b, showed
no growth defect (Figures 2H and 2I), nor did NIH3T3 cells
in which POT1a and POT1b were simultaneously knocked
down to 30% with shRNA (data not shown). Thus,
immortalized cells can proliferate normally without either
POT1a or POT1b or when the total POT1 level is lowered
2- to 3-fold but not in the complete absence of both
POT1a and POT1b.
Repression of the Telomere DNA Damage
Signal by POT1a and POT1b
The role of POT1a and POT1b in the repression of the DNA
damage signal at telomeres was assayed based on the
formation of telomere dysfunction-induced foci (TIFs)
(Takai et al., 2003), which are cytological foci of DNA
damage response factors, such as 53BP1 and g-H2AX,at chromosome ends. When both POT1a and POT1b
were deleted, 70%–80% of the nuclei contained gH2AX
and 53BP1 foci at most of the telomeres (Figures 3A–3C),
indicating that the majority of chromosome ends had lost
protection. Cells lacking only POT1b or cells heterozygous
for POT1a and POT1b did not show this phenotype (Fig-
ures 3A, 3C, and S3A). A TIF response was also observed
upon deletion of POT1a alone but the phenotype was
limited to30%of the cells (Figures 3A and 3C), indicating
that POT1b contributed to the protection of telomeres.
The data suggest that POT1a is sufficient to repress
DNA damage signaling at telomeres even when POT1b
is absent. However, POT1b contributes to telomere pro-
tection and a complete telomere DNA damage response
is only observed when both proteins are removed from
the telomeres. DKO cells retained TRF2 and its interacting
factor Rap1 at their telomeres (Figure 3D). Inspection of
large numbers of nuclei before and after introduction
of Cre showed no obvious change in the IF patterns and
intensity of TRF2 and Rap1. In addition, there was
widespread colocalization of TRF2/Rap1 signals with g-
H2AX in the DKO cells (Figure 3D). Thus, while TRF2 con-
tributes to the recruitment of POT1 (Loayza and de Lange,
2003), POT1a/b are not needed for the accumulation of
TRF2 and Rap1 at telomeres. Furthermore, the results in-
dicate that telomeres lacking POT1a/b have lost the ability
to prevent activation of a DNA damage signal, even
though TRF2 is still present.
Whereas both POT1a and POT1b contribute to the re-
pression of the DNA damage response at telomeres, the
data suggested that POT1a and POT1b are not inter-
changeable in terms of this function. In order to further ex-
plore the possibility that POT1a and POT1b differ in their
ability to repress the telomere DNA damage response,
we monitored the ability of overexpressed myc-tagged
POT1a and POT1b to repress the formation of TIFs in
POT1a/ cells. Both proteins were overexpressed and
localized to telomeres (Figures 3F and S3B) but differed
in their ability to protect the telomeres. Overexpression
of POT1a diminished the frequency of TIF positive cells
by 10-fold, whereas overexpression of POT1b had only
a minor effect (Figure 3E). These data point to a functional
difference between POT1a and POT1b and argue against
the possibility that the distinct phenotypes of POT1a and(B) Genotyping PCR for POT1a and POT1b using DNA from MEFs.
(C) Table of the genotypes found in the offspring of heterozygous intercrosses of indicated POT1a or POT1b mutant mice at weaning (top) or at E13.5
(bottom).
(D) Photograph of POT1bSTOP/+ (left) and POT1bSTOP/STOP (right) mice.
(E) Immunoblot POT1b extracts from MEFs of the indicated genotypes and 129SV/J ES cells using antibody 1223 detecting POT1b (top band). For
the +Cre lane, POT1bSTOP/FLOX MEFs were infected with H&R-Cre virus and analyzed 5 days later.
(F) ChIP using the indicated antibodies on MEFs with the indicated genotype.
(G) Genotyping PCR and immunoblot analysis of POT1amutantMEFs of the indicated genotype. Immunoblots with POT1a antibody 1221 and POT1b
antibody 1223. Cells were infected with H&R-Cre virus were analyzed 5 days post infection (+Cre).
(H) Graph showing growth curves of SV40-LT immortalized MEFs targeted for either POT1a, or both POT1 genes after infection with pWZL-Cre or
vector control viruses. Cells were selected with hygromycin for 96 hr, and proliferation was monitored over the next 7 days in medium without
hygromycine. S/F, STOP/FLOX.
(I) Phase-contrast microscopic images ofMEFs with the indicated genotypes with or without the infection with Cre adenovirus at 7 days after infection
(stained for SA-b-galactosidase).Cell 126, 63–77, July 14, 2006 ª2006 Elsevier Inc. 67
Figure 3. DNA Damage Signal at Telomeres Lacking POT1 Function
(A) MEFs of the indicated POT1 genotypes were infected either with pWZL-Cre retroviruses or control vector, selected for 5 days with hygromycine,
and analyzed by IF for TRF1 (red), g-H2AX (green), and counterstained with DAPI (blue).
(B) FISH-IF analysis of POT1 DKO cells treated as in (A), stained for telomeric DNA (red), 53BP1 (green), and DAPI (blue).68 Cell 126, 63–77, July 14, 2006 ª2006 Elsevier Inc.
POT1b deletion are due to slight differences in the level of
expression of the two genes.
Infrequent Chromosome-End Fusions in DKO Cells
Although many metaphases from the DKO cells showed
no aberrations (Figure 4A, panel I), approximately 60%
of the metaphases contained one or a few aberrant chro-
mosomes (Figures 4A and 4B). Metaphase spreads in
which telomeres were detected using FISH revealed the
occurrence of chromosome-type fusions with telomeric
DNA at the fusion site (Figure 4A, panels II–VI). These
fusions affected 2% of the chromosomes, which is 30-
fold more frequent than in control cells (Figure 4B). The
increase in fusions in DKO cells was significant and de-
pended on the introduction of Cre (Figure 4B). However,
the phenotype is much less pronounced than the nearly
complete fusion phenotype of cells lacking TRF2 in which
each chromosome undergoes one or two fusion events
(Celli and de Lange, 2005). Furthermore, whereas TRF2
null cells have long trains of fused chromosomes, fusions
of more than two chromosomes were rare in POT1 DKO
cells (Figure 4A, panels II, III, and VI). The chromosome-
type fusions occurred on both the short and long arm
and in some cases clearly involved two different chromo-
somes (e.g., Figure 4A, panel IV). The fusions of two chro-
mosomes always involved both chromatids, suggesting
that most fusions occurred before DNA replication.
In addition to chromosome-type telomere fusions, DKO
cells contained a significant number of chromosome
fusions without detectable telomeric DNA at the fusion
site (Figures 4A, panel IX, and 4B), which could be a conse-
quence of breakage-fusion-bridge cycles. Consistent with
this possibility, anaphase bridges were observed and oc-
casionally, chromatin bridges containing telomeric signals
persisted after reformation of the nuclear envelope (Fig-
ure 4A, panel X). DKO cells also contained a few complex
chromosomal rearrangements as well as chromosomes
with multiple TTAGGG repeat FISH signals separated by
large segments of nontelomeric DNA (Figure 4A, panel
IX). The origin of these rare abnormalities is not clear.
POT1 DKO cells appeared to have an unusual propen-
sity to fuse or associate sister telomeres (Figures 4A,
panels VII and VIII, and 4B). Although sister telomere fu-
sions have been observed in cells lacking TRF2 (Smogor-
zewska et al., 2002), they are rare and the vast majority of
fusions involve nonsister telomeres (Bailey et al., 2001). In
order to distinguish sister telomere fusion from spurious
juxtaposition, we only analyzed the q arm telomeres of
chromosomes with clearly separated long arms. Theselong-arm sister telomeres of DKO cells showed a rate of
sister fusion of 1%–2% of the chromosomes per cell di-
vision which is comparable to the rate of nonsister fusions.
Each of the chromosomal abnormalities observed in
DKO cells were also present in POT1a-deficient cells but
at significantly reduced frequency (Figure 4B). In contrast,
POT1b-deficient cells showed no increase in telomere
fusions or other chromosomal abnormalities (Figure 4B).
Thus, POT1a appears to be sufficient for the protection
of telomeres from inappropriate fusion and in its absence
POT1b can partially, but not fully compensate for this
function. However, the telomere fusion phenotype of
DKO cells is minor compared to the phenotype of
TRF2/ cells, indicating POT1 function is largely dispens-
able for the repression of NHEJ at telomeres.
Endoreduplication with Formation
of Diplochromosomes
POT1a/b DKO cells displayed extensive endoreduplica-
tion (Figures 5 and S4). As a result, some of the DKO inter-
phase nuclei had an increased size and contained super-
numerary telomeric signals (see for example Figure 5A). In
these nuclei, the telomeres tended to cluster around re-
gions of more intense DAPI staining, which is expected
since half of the mouse telomeres abut the centromeric
heterochromatin. Metaphase spreads revealed a high fre-
quency (17%) of endoreduplicated karyotypes in which
all chromosomes were present as diplo- or quadruplo-
chromosomes (Figures 5B and S4B). Endoreduplication
with formation of diplochromosomes is rare in immortal-
ized control MEFs (%3% of metaphases; Figures S4A
and S4B). FACS analysis showed that POT1a/b DKO in-
duced an increase in cells with 8N and 16N DNA content
(Figures 5C and 5D), consistent with one and two rounds
of endoreduplication, respectively.
The repression of endoreduplication by POT1 proteins
followed the pattern seen for repression of the DNA dam-
age signal and (rare) telomere fusions. POT1a-deficient
cells exhibited endoreduplication with formation of diplo-
chromosomes in approximately 17% of the metaphase
spreads (Figure S4B). However, FACS analysis indicated
that their extent of endoreduplication was somewhat
less than the DKO cells and metaphases with quadruplo-
chromosomes were not observed (Figure S4A and data
not shown). FACS analysis and inspection of metaphase
spreads showed that endoreduplication was not induced
in POT1b-deficient cells (Figures S4A and S4B). Thus, also
with regard to endoreduplication, POT1a is primarily re-
sponsible for repression of this phenotype. Themechanism(C) Quantification of TIF-positive cells. Cells with 10 or more TRF1 signals colocalizing with gH2AX foci were scored, nR 100. Gray bars, no Cre,
control vector; green bars, pWZL-Cre.
(D) POT1aSTOP/FLOX POT1bSTOP/FLOX examined before and after Cre expression as in (A) but using antibodies to TRF2 (1254, red) or Rap1(1252, red)
and g-H2AX (green) for IF. The images of nucleiCre and + Cre are not shown at the samemagnification. Cre-treated nuclei are considerably larger.
(E) Suppression of the DNA damage response in POT1a/ cells by POT1a but not POT1b. POT1aSTOP/FLOX cells were treated with Cre to delete
POT1a and subsequently infected with retroviruses expressing N-terminally myc-tagged POT1a or POT1b (or the empty pLPC myc vector), as indi-
cated. TIFs were detected and scored as in panels (A) and (C).
(F) Immunoblot detection of POT1a and POT1b overexpression in POT1a- or POT1b-deficient cells. Genotypes and overexpression as indicated
above the lane. Myc-tagged POT1a migrates slightly slower than the endogenous POT1a.Cell 126, 63–77, July 14, 2006 ª2006 Elsevier Inc. 69
Figure 4. Mild Telomere Fusion Phenotype Associated with POT1 Deficiency
(A) Metaphase spreads of SV40-LTMEFswith telomeric DNA detected by FISH (green); DNA stained with DAPI (false-colored in red). POT1aSTOP/FLOX
POT1bSTOP/FLOX MEFs were infected with AdCre and analyzed 78 hr later. Representative metaphase (I). Examples of the chromosomal aberrations
found in the POT1 DKO: chromosome-type fusions with and without telomeric DNA at the site of fusion (II–VI), sister telomere fusions (VII–VIII),
chromosomes with multiple internal TTAGGG signals (IX), and two nuclei connected with multiple chromatin bridges containing telomeric
signals.
(B) Frequencies of aberrant chromosomes in metaphases (as in [A]) of POT1a- and/or POT1b-deficient MEFs. Fusions of short arm sister telomeres
were not scored.by which loss of POT1 function induces endoreduplication
is not known. Chromosome-end fusions are not a likely
culprit since they are thought to impede the progression
of mitosis after resolution of the centromeric cohesin
and hence do not explain the occurrence of diplochromo-
somes which retain cohesion at the centromeres.
POT1b Controls Telomerase-Independent
Processing of the Telomere Terminus
The structure of the telomeres in cells lacking POT1a and/
or POT1b was examined by genomic blotting of telomeric
restriction fragments (Figures 6 and S5). Although each
mouse embryo has a different pattern of telomeric restric-70 Cell 126, 63–77, July 14, 2006 ª2006 Elsevier Inc.tion fragments, the size of the bulk telomeres can be as-
sessed when the DNA is fractionated on CHEF gels. This
analysis indicated that deletion of POT1a or POT1b did
not result in a rapid loss or elongation of telomeric DNA.
Furthermore, the size of the telomeric fragments of sec-
ond-generation POT1b-deficient mice was unaltered (Fig-
ure 6C). In addition, DKO cells had telomeres in a normal
size range, consistent with the retention of the telomeric
FISH signals in interphase cells and metaphase spreads
(Figures 3–5).
The status of the telomere terminus was examined by
quantitative analysis of the 30 telomeric overhang. The
single-stranded telomeric DNA was detected in native
Figure 5. Endoreduplication with Diplo- and Quadruplochromosomes in DKO Cells
(A) Example of enlarged DKO nuclei with supernumerary telomeres. Top panel: TRF1 IF (red) in POT1 DKO cells counter stained with DAPI (blue). The
nucleus on the left is enlarged and shows increased numbers of telomeric TRF1 foci and telomere clustering around heterochromatin. The nucleus
on the right is of normal size. Bottom: Telomeric FISH (green) in DKO cells counter stained with DAPI (blue). Enlarged nucleus with supernumerary
telomeres on the right shown next to a nucleus of normal size.
(B) Telomeric FISH on DKO metaphase chromosomes showing diplochromosomes and quadruplochromosomes.
(C) FACS profiles of POT1aSTOP/FLOX POT1bSTOP/FLOX MEFS infected with pWZL-Cre or vector control, selected for 5 days, and analyzed 2 days after
selection. Sub-G1 cells are not shown.
(D) MEFs were treated as in (C) and incubated in BrdU for 1 hr prior to harvesting. FACS profiles represent BrdU content and DNA content. Numbers
represent % of cells in each compartment.DNA gels using a single-stranded [CCCTAA]4 probe. After
quantification of the signal, the DNA was denatured in situ
and the total amount of telomeric DNA was determined in
the same lane by rehybridization with the [CCCTAA]4
probe. The ratios of single-stranded to total telomeric
DNA signals were compared between samples in order
to evaluate changes in the single-stranded TTAGGG re-
peatDNA.The relativeamountof single-strandedTTAGGG
repeats was not altered upon deletion of POT1a (Figures
6A, 6B, and S5). In contrast, loss of POT1b resulted in in-
creased single-stranded telomeric DNA signals (Figures
6A and 6B). The increased signal was derived from a 30
overhang since it was sensitive to theE. coli 30 exonuclease
ExoI (Figure S5A). POT1bSTOP/STOP mice showed a 7- to
11-fold increase in the overhang signal in liver, kidney,
and spleen, and this phenotype was stable over twogenerations (Figure 6C and data not shown). It appeared
that the overhangs in POT1b-deficient MEFs gradually in-
creased with proliferation (data not shown), consistent
with the greater amount of ss TTAGGG DNA in vivo.
Cells lacking both POT1a and POT1b had a similar over-
hang extension phenotype as POT1b-deficient cells (Fig-
ures 6A, 6B, and S5). Due to the rapid arrest of the DKO
cells, we could not determine whether POT1a loss exacer-
bates the phenotype. The DKO cells contained a class of
overhang-bearing telomeric restriction fragments that mi-
grated throughout the lane, suggesting an unusual DNA
structure. The smearing of the signal into the higher MW
fractions and beyond was not prominent when the total
telomeric DNA was examined after denaturation of the
DNA, indicating that these molecules were relatively rare
and only detectable due to their longer overhangs.Cell 126, 63–77, July 14, 2006 ª2006 Elsevier Inc. 71
72 Cell 126, 63–77, July 14, 2006 ª2006 Elsevier Inc.
In order to establish whether the elongation of the over-
hangs was a specific phenotype of loss of POT1b, we de-
termined to what extent exogenously expressed POT1a
and POT1b were able to suppress this phenotype of
POT1b-deficient cells. As shown above (Figures 3F and
S3B), both proteins were overexpressed and localized to
telomeres. POT1b was able to reestablish a normal telo-
mere terminus structure, whereas POT1a overexpression
had no effect (Figure 6D). We conclude that the control of
the telomeric overhang is primarily dependent on POT1b.
We next asked whether the extended telomeric over-
hangs are due to deregulation of telomerase at the telo-
mere terminus. POT1b mutant mice were crossed with
mice that lack telomerase due to deletion of the mTERC
gene encoding the RNA component of telomerase (Blasco
et al., 1997). MEFs that lacked mTERC and had a condi-
tional POT1b allele were established and immortalized
with SV40-LT. Cre-mediated POT1b deletion resulted in
comparable extension of the 30 overhang in both
mTERC+/ and mTERC/ cells, indicating that telome-
rase is not responsible for the elongation of the 30 ends
(Figure 6E). We conclude that POT1b maintains the integ-
rity of the telomere terminus by regulating a telomerase-
independent processing step.
DISCUSSION
Our results reveal an unexpected difference between
human and rodent shelterin. Human shelterin contains a
single POT1 protein, whereas the mouse version of this
complex is more elaborate, containing roughly equal
levels of two functionally distinct POT1 proteins, POT1a
and POT1b. Since their duplication, the two mouse
POT1 paralogs diverged to the extent that full protection
of the telomeres requires both factors. For example,
POT1a is necessary to fully repress a DNA damage signal
at telomeres. POT1b can partially compensate for the loss
of POT1a, but its ability to repress the telomere damage
response is incomplete. Conversely, POT1b has a specific
role in regulating the structure of the telomere terminus,
leading to deregulation of the telomeric overhang in
POT1b-deficient cells, despite the presence of POT1a.
Thus, while POT1a and POT1b are relatively recent addi-tions to shelterin, they have distinct functions and are
both required for the protection of mouse telomeres. It is
possible that the single human POT1 protein combines
the functions of mouse POT1a and POT1b although at-
tempts at complementation with human POT1 have so
far failed (D.H. and T.d.L., unpublished data).
Within the context of fundamental aspects of mamma-
lian chromosome biology, the rodent duplication of the
POT1 gene and functional divergence of the two resulting
POT1 paralogs is unprecedented. No comparable case
has emerged from comparisons of human and mouse
genes involved in kinetochore function, origin firing and
regulation, or DNA damage detection and repair. Other
genes relevant to telomere biology, such as those for telo-
merase components and the genes for the other shelterin
proteins are present at single copy in all sequenced mam-
malian genomes. Previous findings revealed substantial
differencesbetween the telomeric proteins inbudding yeast
on the one hand and fission yeast and mammals on the
other. The current results provide evidence for much
more recent changes in the telomeric complex and attest
to the rapid evolution of the telomere/telomerase system.
POT1a and POT1b Play a Key Role in Repressing
the Telomere DNA Damage Response
POT1a/b DKO cells lack the ability to distinguish telo-
meres from sites of DNA damage. Most of their telomeres
become associated with DNA damage response factors
and the cells arrest, most likely due to a permanent DNA
damage signal. The severity of this telomere damage phe-
notype is similar to that of mouse cells lacking TRF2 (Celli
and de Lange, 2005). Yet, TRF2 is not removed from telo-
meres lacking POT1a/b. This finding raises the possibility
that the POT1 proteins contribute to the mechanism
by which TRF2 prevents DNA damage signaling at chro-
mosome ends (Figure 7). The recruitment of POT1 to
telomeres is thought to depend on both TRF1 and TRF2,
which bring the POT1 interacting factor TPP1 to the telo-
mere (reviewed in de Lange, 2005). While these interac-
tions have not been verified in mouse cells, the residues
required for TPP1 binding are conserved in mouse
POT1a and POT1b. Thus, the DNA damage phenotype
of TRF2 null mouse cells could be solely due to insufficientFigure 6. POT1b Controls a Telomerase-Independent Telomere Terminus Processing Step
(A) DNA from MEFs of the indicated genotypes were analyzed using the in-gel telomere overhang assay. Phenotypes were analyzed 7 days after in-
fection with H&R-Cre or without infection at the same time point. The left image shows hybridization signal using the TelC probe ([CCCTAA]4) under
native conditions detecting the telomeric 30 overhang. The right image shows the total telomeric hybridization signal obtained with the same probe
after in-gel denaturation of the DNA. MEFs are derived from littermate embryos and were analyzed 1 week after introduction of Cre.
(B) Quantification of overhang changes based on three independent experiments as shown in (A). Bar graphs represent quantified overhang signals
normalized to the total telomeric signal in the same lane. For each genotype, % overhang change induced by Cre are depicted. Error bars represent
one SD.
(C) In-gel overhang assay of cells isolated from liver and kidney from mice with the indicated genotype. Left panel shows the native overhang signal,
right panel shows the denatured total telomeric DNA. Relative overhang signals are indicated below the lanes. (D) Repression of the overhang phe-
notype by overexpression of POT1b, not POT1a. POT1bSTOP/+ or POT1bSTOP/FLOX cells were treated with Cre and infected with retroviruses express-
ing myc-tagged POT1a or POT1b as shown in Figure 3F. Telomeric overhang signals were determined as in panel (A).
(E) In-gel overhang assay of MEFs either heterozygous or null for mTerc and conditionally targeted for POT1b with or without H&R-Cre infection. Left
panel shows the native overhang signal, right panel shows the denatured total telomeric DNA. All MEFs are derived from littermates embryos. MEFs
were examined 1 week after introduction of Cre. MEFs in lanes (from left) 3, 4, 5, 6, 9, and 10 were POT1aFLOX/+.Cell 126, 63–77, July 14, 2006 ª2006 Elsevier Inc. 73
Figure 7. Summary of the Roles of TRF2,
POT1a, and POT1b at Mouse Telomeres
Mouse shelterin is depicted as a complex of
TRF1, TRF2, Rap1, TIN2, TPP1, and POT1a
and POT1b. The details of the protein interac-
tions are in part based on information from hu-
man shelterin. It is not known whether POT1a
and POT1b are present in the same complex
or in two different versions of shelterin. Repres-
sion of the DNA damage signal at telomeres re-
quires TRF2, POT1a and POT1b. Repression
of NHEJ is largely independent of POT1a
and –b but requires TRF2. NHEJ is proposed
to be repressed through sequestration of the
telomere terminus in the t-loop. POT1a and
POT1b are proposed to repress NHEJ at telo-
meres that are not in the t-loop configuration.
POT1b is required to prevent generation of
inappropriately long telomeric 30 overhangs.POT1 at the chromosome ends but other possibilities
have not been excluded.
The Repression of NHEJ at Telomeres
When TRF2 is deleted, most telomeres are processed by
the NHEJ pathway, leading to nearly complete fusion of
the genome (Celli and de Lange, 2005). In contrast, telo-
meres lacking POT1a andPOT1b remain largely protected
from this type of inappropriate repair. This result indicates
that POT1 is not required for the repression of most NHEJ
events and is consistent with NHEJ being blocked by the
formation of t-loops, a process ascribed toTRF2 (Figure 7).
However, a small fraction of the chromosome ends in
POT1 DKO cells do undergo fusions, pointing to an impor-
tant, albeit minor role of POT1a/b in the repression of
NHEJ. One possibility is that POT1a/b aids in repression
of NHEJ when t-loops are resolved (Figure 7), for instance
when the replication fork progresses through the strand-
invasion site. We imagine that the presence of POT1a/b
on the single-stranded overhang might interfere with effi-
cient loading of Ku70/80 or prevent cleavage of the over-
hang, thereby thwarting NHEJ.
POT1b Blocks Formation of Excessive
Single-Stranded Telomeric DNA
The maintenance of the normal structure of the telomere
terminus is dependent on POT1b. In its absence, cells
contain up to 10-fold more single-stranded TTAGGG re-
peat DNA. Although we do not know whether the increase
in overhang sequences affects all telomere equally, if it
does, the overhangs may be as long as 2 kb. The total
amount of single-stranded TTAGGG repeat DNA could
be in excess of 200 kb in the nuclei of liver cells lacking
POT1b. This type of alteration has not previously been ob-
served in mammalian cells, nor does it occur in fission74 Cell 126, 63–77, July 14, 2006 ª2006 Elsevier Inc.yeast lacking POT1 (Baumann and Cech, 2001). However,
in the budding yeast cdc13-1 mutant, inactivation of the
POT1-like Cdc13 protein results in excessively long 30
overhangs (Garvik et al., 1995). The long single-stranded
regions are thought to activate the MEC1/RAD9 pathway,
explaining the lethality of cdc13-1. In contrast, the excess
single-stranded DNA of POT1b-deficient cells did not
appear to activate a DNA damage checkpoint and mice
lacking POT1b are healthy and fertile. In the cdc13-1 mu-
tant, the long 30 overhangs are generated by exonucleo-
lytic degradation of the C-rich telomeric DNA strand in
an Exo1- and Rad24-dependent manner (Zubko et al.,
2004). A similar mechanism may well be responsible for
the excess single-stranded telomeric DNA in POT1b-defi-
cient cells (Figure 7). In this regard, RNAi-mediated knock-
down of human POT1 results in an altered sequence at the
50 end of the C-rich telomeric repeat strand which could
also be a consequence diminished control of a 50 exonu-
clease (Hockemeyer et al., 2005).
More Than One Pathway for Telomere Protection
The results argue againstmodels inwhich all telomere pro-
tection is simply based on the loading of one protective
protein. Rather, different shelterin components have dis-
tinct as well as overlapping roles in preventing inappropri-
ate DNA damage signaling and repair at chromosome
ends (Figure 7). POT1b is required for the maintenance of
a normal telomere terminus structure. Neither POT1a nor
TRF2 have the ability to control this pathway when
POT1b is absent. On the other hand, complete repression
of DNA damage signaling at telomeres requires POT1a.
POT1b is insufficient to fully protect telomeres in this re-
gard although its contribution to this pathway is inferred
from the more severe telomere damage phenotype of the
DKO cells. TRF2 is also required for repression of the
telomere DNAdamage signal although it remains to be de-
termined whether its function is independent of POT1a/b.
In contrast, the protection of telomeres from NHEJ in-
volves apathway that requires TRF2but is largely indepen-
dent of the POT1 paralogs. The simplest interpretation of
these findings is that telomere protection is achieved
through at least three distinct pathways: POT1b-depen-
dent control of the terminus structure; repression of
a DNA damage signal involving TRF2, POT1a, and
POT1b; and TRF2-dependent repression of NHEJ. In
addition, telomeres are protected from inappropriate
homologous recombination, but the genetic requirements
for this aspect of telomere function remain largely unde-
fined (Wang et al., 2004).
Implications
The unusual divergence of mouse shelterin has implica-
tions for the use of mouse models for human telomere-
related disease states. Deletion of essential telomerase
components has allowed the establishment of mice with
shortening telomeres that ultimately become dysfunc-
tional andmimic aspects of telomere dysfunction in human
cells (Blasco et al., 1997; Erdmann et al., 2004). These
systems have been used to study the impact of telomere
dysfunction on tumorigenesis, revealing that telomere
dysfunction can limit tumor progression in some settings
while promoting genome instability in others (Artandi
et al., 2000; Greenberg et al., 1999; Maser and DePinho,
2002). Furthermore, the telomerase-knockout mouse has
been used tomodel aspects of the human telomerase dis-
ease, dyskeratosis congenita (Armanios et al., 2005), and
to study interactions between shortening telomeres and
genetic defects such as Ataxia Telangiectasia andWerner
syndrome (Laud et al., 2005; Qi et al., 2003; Wong et al.,
2003). Similarly, we have used a mouse TRF2-knockout
model to dissect the signaling pathway activated by dys-
functional telomeres (Celli anddeLange, 2005). Interpreta-
tion of these and other experiments rely on the assumption
that mouse and human telomeres are structurally and
functionally identical. The finding of an altered shelterin
at mouse telomeres challenges this assumption. As more
refinedmouse models are developed, the potential pitfalls
of working within the context of a different shelterin com-
plex will have to be taken into account and the principles
gleaned from work on mouse telomeres will require de-
tailed verification in human cells.
EXPERIMENTAL PROCEDURES
Mice and MEFs with Altered POT1 Alleles
POT1a8GEO/+ mice were generated from the Baygenomics clone
RRA096. Gene-targeting constructs for POT1a and POT1b were gen-
erated using appropriate restriction fragments from BAC clones sub-
cloned into pSL301 (Invitrogen) next to a DTA cassette. A STOP cas-
sette (Jackson et al., 2001) flanked by FRT sites was introduced. The
constructs also contained a puromycin resistance gene next to the
STOP cassette and a neomycin resistance gene flanked by LoxP sites.
A third LoxP site was introduced by inserting an oligonucleotide that
also introduced a BamHI restriction site used for the analysis of target-ing in ES cells. Targeted ES cell clones were injected into C57BL/6J
blastocysts, and chimeric founders were crossed to C57BL/6J fe-
males. Mice were kept in a mixed 129/ C57BL/6J background.
FLOXed alleles were generated by removing the STOP cassette using
a FLPe deleter mouse stain (Jackson Labs). mTERC-deficient mice
(Blasco et al., 1997) were obtained from R.A. DePinho and C.W.
Greider. MEFs were isolated from a cross of a male POT1bSTOP/FLOX
mTERC/ mouse and a female POT1bFLOX/FLOXmTERC+/ mouse.
Primary MEFs from E13.5 embryos were immortalized at passage 2
with pBabeSV40LT (a gift from G. Hannon). Cre was introduced using
Hit&Run Cre-GFP (Silver and Livingston, 2001), pWZL-Cre, or Ad5
CMV Cre (Resource Center, The University of Iowa, Iowa City, IA)
and deletion was monitored by PCR. POT1 proteins were stably
knocked down in NIH3T3 cells using pSicoR-GFP vector technology
(Ventura et al., 2004; a gift from T. Jacks).
ChIP, IF, and Immunoblotting
ChIPs were performed as described previously (Loayza and de Lange,
2003; Ye et al., 2004) with the difference that a probe for the BamHI
repeat element (Fanning, 1983) was used to detect bulk genomic
DNA. Immunoblots and IF for POT1a and POT1b were performed
using the protocols described previously (Hockemeyer et al., 2005;
Loayza and de Lange, 2003). POT1a antibodies 1220 and 1221 were
raised in rabbits against a POT1a peptide representing amino acids
395–421. POT1b antibodies 1222 and 1223 were raised against
a POT1b peptide representing amino acids 285–307. IF for g-H2AX
was performed using a mouse agH2AX antibody (Upstate Biotech-
nology, Lake Placid, NY); 53BP1 FISH/IF staining was performed using
a polyclonal rabbit anti human 53BP1 antibody, (Novus, [NB 100-304])
using the protocol developed by Sedivy and colleagues (Herbig et al.,
2004). POT1a IF was performed using a mouse antibody against GST-
POT1a fusion protein. POT1b IF was performed using a mouse anti-
body against GST-fused to POT1b (aa 1–342). TRF1 IF was performed
with Ab 644 (Karlseder et al., 2003).
Analysis of Telomeric DNA
Mouse telomeric DNAwas analyzed onCHEF gels using previously de-
scribed protocols (Celli and de Lange, 2005). FISH for telomeric DNA
waspreformedasdescribed (Celli anddeLange, 2005),with theexcep-
tion that a FITC-TelC (FITC-OO-CCCTAACCCTAAACCCTAA, Applied
Biosystems) probe was used to detect telomeric DNA.
Detailed Supplemental Experimental Procedures are available in the
Supplemental Data.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
five figures, and Supplemental References and can be found with
this article online at http://www.cell.com/cgi/content/full/126/1/63/
DC1/.
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